Tetsuya Hamaguchi

11.9k total citations
217 papers, 4.5k citations indexed

About

Tetsuya Hamaguchi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Tetsuya Hamaguchi has authored 217 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 145 papers in Oncology, 106 papers in Pulmonary and Respiratory Medicine and 63 papers in Surgery. Recurrent topics in Tetsuya Hamaguchi's work include Colorectal Cancer Treatments and Studies (91 papers), Gastric Cancer Management and Outcomes (77 papers) and Cancer Treatment and Pharmacology (36 papers). Tetsuya Hamaguchi is often cited by papers focused on Colorectal Cancer Treatments and Studies (91 papers), Gastric Cancer Management and Outcomes (77 papers) and Cancer Treatment and Pharmacology (36 papers). Tetsuya Hamaguchi collaborates with scholars based in Japan, United States and United Kingdom. Tetsuya Hamaguchi's co-authors include Yasuhiro Shimada, Yasuhide Yamada, Ken Kato, Yasuhiro Matsumura, Kuniaki Shirao, Atsuo Takashima, Takako Eguchi Nakajima, Satoru Iwasa, Natsuko Okita and Yoshitaka Honma and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Tetsuya Hamaguchi

204 papers receiving 4.4k citations

Peers

Countries citing papers authored by Tetsuya Hamaguchi

Since Specialization

Citations

This map shows the geographic impact of Tetsuya Hamaguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsuya Hamaguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsuya Hamaguchi more than expected).

Fields of papers citing papers by Tetsuya Hamaguchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsuya Hamaguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsuya Hamaguchi. The network helps show where Tetsuya Hamaguchi may publish in the future.

Co-authorship network of co-authors of Tetsuya Hamaguchi

This figure shows the co-authorship network connecting the top 25 collaborators of Tetsuya Hamaguchi. A scholar is included among the top collaborators of Tetsuya Hamaguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tetsuya Hamaguchi. Tetsuya Hamaguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long-term follow-up of the conventional versus no-touch isolation technique for resection of primary colon cancer (JCOG1006): randomized clinical trial 2024 ·BJS Open ·Koji Komori, Yasumasa Takii, Junki Mizusawa, Yukihide Kanemitsu, Manabu Shiozawa, Masayuki Ohue, Satoshi Ikeda, Takaya Kobatake, Tetsuya Hamaguchi, Hiroshi Katayama, Haruhiko Fukuda	0
2	Localized colorectal cancer database integrating 4 randomized controlled trials; (JCOG2310A) 2024 ·European Journal of Surgical Oncology ·Kozo Kataoka, Akira Ouchi, Yusuke Suwa, Hidekazu Hirano, (unknown), (unknown), Marie Hanaoka, (unknown), Shogen Boku, K Nagata, (unknown), Yasuhiro Shimada, Masafumi Inomata, (unknown), Junki Mizusawa, Tetsuya Hamaguchi, Yasumasa Takii, Shunsuke Tsukamoto, Atsuo Takashima, Yukihide Kanemitsu	0
3	A randomized phase II study comparing preoperative mFOLFOX6 versus FOLFOXIRI for locally advanced colon cancer: JCOG2006 2023 ·Future Oncology ·(unknown), Tadayoshi Hashimoto, Satoshi Maruyama, Yasumasa Takii, Junki Mizusawa, Tomoko Kataoka, Haruhiko Fukuda, Shunsuke Tsukamoto, Atsuo Takashima, Tetsuya Hamaguchi, Yukihide Kanemitsu	0
4	Primary Tumor Resection Plus Chemotherapy Versus Chemotherapy Alone for Colorectal Cancer Patients With Asymptomatic, Synchronous Unresectable Metastases (JCOG1007; iPACS): A Randomized Clinical Trial 2021 ·Journal of Clinical Oncology ·Yukihide Kanemitsu, Kohei Shitara, Junki Mizusawa, Tetsuya Hamaguchi, Dai Shida, Koji Komori, Satoshi Ikeda, Hitoshi Ojima, Hideyuki Ike, Akio Shiomi, Jun Watanabe, Yasumasa Takii, Tomohiro Yamaguchi, Kenji Katsumata, Masaaki Ito, Junji Okuda, Ryoji Hyakudomi, Yasuhiro Shimada, Hiroshi Katayama, Haruhiko Fukuda, (unknown)	115
5	Study protocol for a multi-institutional randomized phase III study comparing combined everolimus plus lanreotide therapy and everolimus monotherapy in patients with unresectable or recurrent gastroenteropancreatic neuroendocrine tumors; Japan Clinical Oncology Group Study JCOG1901 (STARTER-NET study) 2020 ·Pancreatology ·Ryo Shimoyama, Susumu Hijioka, Nobumasa Mizuno, Gakuto Ogawa, Tomoko Kataoka, Hiroshi Katayama, Nozomu Machida, Yoshitaka Honma, Narikazu Boku, Tetsuya Hamaguchi, Haruhiko Fukuda, Masanori Terashima, Yukihide Kanemitsu, Junji Furuse	7
6	Tumor-to-tumor metastasis from appendiceal adenocarcinoma to an ovarian mature teratoma, mimicking malignant transformation of a teratoma: a case report 2019 ·Diagnostic Pathology ·Mitsutake Yano, (unknown), Tetsuya Hamaguchi, Eito Kozawa, (unknown), Koji Nagata, Masanori Yasuda	10
7	Efficacy of aspirin for stage III colorectal cancer: a randomized double-blind placebo-controlled trial (JCOG1503C, EPISODE-III trial) 2019 ·Japanese Journal of Clinical Oncology ·Ken‐ichi Miyamoto, Atsuo Takashima, Junki Mizusawa, Yuya Sato, Yasuhiro Shimada, Hiroshi Katayama, Kenichi Nakamura, Taro Shibata, Haruhiko Fukuda, Dai Shida, Yukihide Kanemitsu, Tetsuya Hamaguchi	6
8	[Comparison of Response to Chemotherapy between Ovarian and Extraovarian Metastasis of Gastric Cancer]. 2017 ·PubMed ·(unknown), Shoko Nakamura, Yusuke Sasaki, Naoki Takahashi, Satoru Iwasa, Yoshitaka Honma, Natsuko Okita, Atsuo Takashima, Ken Kato, Tetsuya Hamaguchi, Narikazu Boku	1
9	Pretreatment Immune Status Correlates with Progression-Free Survival in Chemotherapy-Treated Metastatic Colorectal Cancer Patients 2016 ·Cancer Immunology Research ·Kohei Tada, Shigehisa Kitano, Hirokazu Shoji, Takashi Nishimura, Yasuhiro Shimada, Kengo Nagashima, Kazunori Aoki, Nobuyoshi Hiraoka, Yoshitaka Honma, Satoru Iwasa, Natsuko Okita, Atsuo Takashima, Ken Kato, Yasuhide Yamada, Naoyuki Katayama, Narikazu Boku, Yuji Heike, Tetsuya Hamaguchi	54
10	Phase I study of combination therapy with irinotecan, leucovorin, and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for advanced colorectal cancer in Japanese patients. 2014 ·PubMed ·Yusuke Sasaki, Tetsuya Hamaguchi, (unknown), Ayumu Goto, Takashi Ura, Kei Muro, Yasuhide Yamada, Kuniaki Shirao, Yasuhiro Shimada	2
11	Randomised phase III trial of adjuvant chemotherapy with oral uracil and tegafur plus leucovorin versus intravenous fluorouracil and levofolinate in patients with stage III colorectal cancer who have undergone Japanese D2/D3 lymph node dissection: Final results of JCOG0205 2014 ·European Journal of Cancer ·Yasuhiro Shimada, Tetsuya Hamaguchi, Junki Mizusawa, Norio Saito, Yukihide Kanemitsu, Nobuhiro Takiguchi, Masayuki Ohue, Takeshi Kato, Yasumasa Takii, Toshihiko Satō, Naohiro Tomita, Shigeki Yamaguchi, Makoto Akaike, Hideyuki Mishima, Yoshiro Kubo, Kenichi Nakamura, Haruhiko Fukuda, Yoshihiro Moriya	90
12	Irinotecan plus cisplatin in patients with extensive-disease poorly differentiated neuroendocrine carcinoma of the esophagus. 2014 ·PubMed ·Hitomi Sumiyoshi Okuma, Satoru Iwasa, Hirokazu Shoji, Atsuo Takashima, Natsuko Okita, Yoshitaka Honma, Ken Kato, Tetsuya Hamaguchi, Yasuhide Yamada, Yasuhiro Shimada	24
13	Phase I study of sunitinib plus modified FOLFOX6 in Japanese patients with treatment-naive colorectal cancer. 2012 ·PubMed ·Takayuki Yoshino, Kentaro Yamazaki, Tetsuya Hamaguchi, Yasuhiro Shimada, Ken Kato, Hirofumi Yasui, Narikazu Boku, María José Lechuga, Tomoko Hirohashi, Atsushi Shibata, Satoshi Hashigaki, (unknown), Atsushi Ohtsu	6
14	Synergistic antitumor activity of the novel SN‐38‐incorporating polymeric micelles, NK012, combined with 5‐fluorouracil in a mouse model of colorectal cancer, as compared with that of irinotecan plus 5‐fluorouracil 2008 ·International Journal of Cancer ·Takako Eguchi Nakajima, Masahiro Yasunaga, Yasuhiko Kano, Fumiaki Koizumi, Ken Kato, Tetsuya Hamaguchi, Yasuhide Yamada, Kuniaki Shirao, Yasuhiro Shimada, Yasuhiro Matsumura	50
15	Impact of Insulin-Like Growth Factor Type 1 Receptor, Epidermal Growth Factor Receptor, and HER2 Expressions on Outcomes of Patients with Gastric Cancer 2008 ·Clinical Cancer Research ·Junichi Matsubara, Yasuhide Yamada, Yoshinori Hirashima, Daisuke Takahari, Natsuko Okita, Ken Kato, Tetsuya Hamaguchi, Kuniaki Shirao, Yasuhiro Shimada, Tadakazu Shimoda	102
16	Clinical Significance of Insulin-Like Growth Factor Type 1 Receptor and Epidermal Growth Factor Receptor in Patients with Advanced Gastric Cancer 2008 ·Oncology ·Junichi Matsubara, Yasuhide Yamada, Takako Eguchi Nakajima, Ken Kato, Tetsuya Hamaguchi, Kuniaki Shirao, Yasuhiro Shimada, Tadakazu Shimoda	48
17	A CASE OF BILE DUCT CARCINOMA WITH SUCCSESSFULLY RESECTED METACHRONOUS RECURRENCES 2007 ·Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) ·Toru Masuda, Tetsuya Hamaguchi, (unknown), Masaki Fujioka	0
18	Genetic variations and haplotype structures of the DPYD gene encoding dihydropyrimidine dehydrogenase in Japanese and their ethnic differences 2007 ·Journal of Human Genetics ·Keiko Maekawa, Mayumi Saeki, Yoshiro Saito, Shogo Ozawa, Kouichi Kurose, Nahoko Kaniwa, Manabu Kawamoto, Naoyuki Kamatani, Ken Kato, Tetsuya Hamaguchi, Yasuhide Yamada, Kuniaki Shirao, Yasuhiro Shimada, Manabu Muto, Toshihiko Doi, Atsushi Ohtsu, Teruhiko Yoshida, Yasuhiro Matsumura, Nagahiro Saijo, Jun-ichi Sawada	52
19	High susceptibility of human c‐Ha‐ras proto‐oncogene transgenic rats to carcinogenesis: A cancer‐prone animal model 2005 ·Cancer Science ·Hiroyuki Tsuda, Katsumi Fukamachi, (unknown), Shinobu Ueda, Yoichiro Matsuoka, Tetsuya Hamaguchi, Takamasa Ohnishi, Nobuo Takasuka, Akihiro Naito	21
20	Pharmaceutical and Biomedical Differences between Micellar Doxorubicin (NK911) and Liposomal Doxorubicin (Doxil) 2002 ·Japanese Journal of Cancer Research ·(unknown), Yasuhiro Matsumura, Tetsuya Hamaguchi, (unknown), Fuminori Moriyasu, Tadao Kakizoe	89

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact